Sebastien J Hotte

8PUBLICATIONS
87CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 20, 2026
Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1.

Mary-Ellen Taplin, Irbaz Bin Riaz, R Bryan Rumble

|Dec 31, 2025
First-in-Human Phase I Clinical Trial of SLC-391, a Novel and Selective AXL Inhibitor, in Patients with Advanced Solid Tumours.

Zaihui Zhang, Donna Morrison, Liang Lu

|May 02, 2025
Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update.

Rohan Garje, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi

|Nov 08, 2024
Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate Cancer.

Eric Winquist, Sebastien J Hotte, Kim Chi

|Mar 27, 2024
<sup>177</sup>Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: A Review of the Evidence and Implications for Canadian Clinical Practice.

Kim N Chi, Steven M Yip, Glenn Bauman

|Oct 20, 2023
Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma.

Daniel P Petrylak, Bernhard J Eigl, Saby George

Pageof 2

Frequent Collaborators

3 joint publications

Kim N Chi

2 joint publications

Irbaz Bin Riaz

2 joint publications

Thomas A Hope

2 joint publications

R Bryan Rumble